David Westenberg
Stock Analyst at Piper Sandler
(4.84)
# 414
Out of 4,994 analysts
555
Total ratings
57.9%
Success rate
19.8%
Average return
Main Sectors:
Stocks Rated by David Westenberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Reiterated: Buy | $54 | $43.36 | +24.54% | 5 | Sep 17, 2026 | |
| GH Guardant Health | Reiterated: Buy | $193 | $177.16 | +8.94% | 41 | Sep 15, 2026 | |
| NEOG Neogen | Reiterated: Buy | $14 | $13.98 | +0.14% | 26 | Sep 15, 2026 | |
| MYGN Myriad Genetics | Downgraded: Sell | $8.5 → $2 | $4.02 | -50.25% | 22 | Sep 1, 2026 | |
| TEM Tempus AI | Upgraded: Buy | $56 → $76 | $77.19 | -1.54% | 17 | Sep 1, 2026 | |
| A Agilent Technologies | Reiterated: Hold | $150 | $167.26 | -10.32% | 2 | Aug 27, 2026 | |
| NEO NeoGenomics | Reiterated: Buy | $21 | $18.89 | +11.17% | 25 | Aug 27, 2026 | |
| WAT Waters | Upgraded: Buy | $400 → $480 | $425.74 | +12.74% | 3 | Aug 27, 2026 | |
| TRUP Trupanion | Downgraded: Hold | $45 → $32 | $23.63 | +35.42% | 10 | Aug 26, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $28 | $28.06 | -2.00% | 38 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $364 | $390.90 | -7.01% | 53 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $22.93 | +30.83% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $47 | $80.70 | -41.76% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $135 → $80 | $72.86 | +9.80% | 27 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $120 | $116.07 | +3.39% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $31.47 | -33.27% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 | $5.71 | +31.35% | 38 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $108.52 | -48.40% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.47 | +36.05% | 30 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $85 → $115 | $164.60 | -30.13% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $19 | $21.65 | -12.24% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $300 → $309 | $311.54 | -0.82% | 8 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 | $90.80 | -30.62% | 14 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $225 | $247.46 | -9.08% | 53 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €80.00 | €74.10 | +7.96% | 2 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $200 | $221.09 | -9.54% | 2 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $510 → $600 | $658.52 | -8.89% | 2 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | €75.00 | €76.50 | -1.96% | 1 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $65 | $72.55 | -10.41% | 1 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $775 → $750 | $521.50 | +43.82% | 27 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $190 → $200 | $234.76 | -14.81% | 12 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 150p → 190p | 179p | n/a | 6 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3.5 → $3 | $4.14 | n/a | 10 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $4.15 | n/a | 1 | Oct 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $35.15 | n/a | 1 | May 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $65 | $186.75 | n/a | 2 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.57 | n/a | 1 | Jun 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $379.57 | n/a | 2 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $52 | $10.94 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $40.23 | n/a | 1 | Dec 7, 2017 |
Veracyte
Sep 17, 2026
Reiterated: Buy
Price Target: $54
Current: $43.36
Upside: +24.54%
Guardant Health
Sep 15, 2026
Reiterated: Buy
Price Target: $193
Current: $177.16
Upside: +8.94%
Neogen
Sep 15, 2026
Reiterated: Buy
Price Target: $14
Current: $13.98
Upside: +0.14%
Myriad Genetics
Sep 1, 2026
Downgraded: Sell
Price Target: $8.5 → $2
Current: $4.02
Upside: -50.25%
Tempus AI
Sep 1, 2026
Upgraded: Buy
Price Target: $56 → $76
Current: $77.19
Upside: -1.54%
Agilent Technologies
Aug 27, 2026
Reiterated: Hold
Price Target: $150
Current: $167.26
Upside: -10.32%
NeoGenomics
Aug 27, 2026
Reiterated: Buy
Price Target: $21
Current: $18.89
Upside: +11.17%
Waters
Aug 27, 2026
Upgraded: Buy
Price Target: $400 → $480
Current: $425.74
Upside: +12.74%
Trupanion
Aug 26, 2026
Downgraded: Hold
Price Target: $45 → $32
Current: $23.63
Upside: +35.42%
Adaptive Biotechnologies
Aug 24, 2026
Reiterated: Buy
Price Target: $28
Current: $28.06
Upside: -2.00%
Aug 24, 2026
Reiterated: Buy
Price Target: $364
Current: $390.90
Upside: -7.01%
Aug 10, 2026
Reiterated: Buy
Price Target: $30
Current: $22.93
Upside: +30.83%
Aug 10, 2026
Reiterated: Hold
Price Target: $42 → $47
Current: $80.70
Upside: -41.76%
Aug 10, 2026
Reiterated: Hold
Price Target: $135 → $80
Current: $72.86
Upside: +9.80%
Aug 6, 2026
Reiterated: Buy
Price Target: $130 → $120
Current: $116.07
Upside: +3.39%
Aug 6, 2026
Reiterated: Hold
Price Target: $21
Current: $31.47
Upside: -33.27%
Aug 6, 2026
Reiterated: Buy
Price Target: $7.5
Current: $5.71
Upside: +31.35%
Aug 6, 2026
Reiterated: Hold
Price Target: $56
Current: $108.52
Upside: -48.40%
Aug 6, 2026
Reiterated: Hold
Price Target: $2
Current: $1.47
Upside: +36.05%
Aug 5, 2026
Rated: Buy
Price Target: $85 → $115
Current: $164.60
Upside: -30.13%
Aug 4, 2026
Reiterated: Hold
Price Target: $15 → $19
Current: $21.65
Upside: -12.24%
Aug 4, 2026
Reiterated: Hold
Price Target: $300 → $309
Current: $311.54
Upside: -0.82%
Aug 4, 2026
Reiterated: Buy
Price Target: $63
Current: $90.80
Upside: -30.62%
Aug 3, 2026
Reiterated: Buy
Price Target: $200 → $225
Current: $247.46
Upside: -9.08%
Jul 29, 2026
Reiterated: Hold
Price Target: €80.00
Current: €74.10
Upside: +7.96%
Jul 27, 2026
Reiterated: Hold
Price Target: $200
Current: $221.09
Upside: -9.54%
Jul 27, 2026
Reiterated: Hold
Price Target: $510 → $600
Current: $658.52
Upside: -8.89%
Jun 11, 2026
Initiated Coverage: Hold
Price Target: €75.00
Current: €76.50
Upside: -1.96%
Jun 11, 2026
Initiated Coverage: Hold
Price Target: $65
Current: $72.55
Upside: -10.41%
Feb 9, 2026
Reiterated: Hold
Price Target: $775 → $750
Current: $521.50
Upside: +43.82%
Oct 27, 2025
Reiterated: Hold
Price Target: $190 → $200
Current: $234.76
Upside: -14.81%
Sep 3, 2025
Reiterated: Buy
Price Target: 150p → 190p
Current: 179p
Upside: n/a
Nov 13, 2023
Rated: Hold
Price Target: $3.5 → $3
Current: $4.14
Upside: n/a
Oct 4, 2021
Initiated Coverage: Buy
Price Target: $28
Current: $4.15
Upside: n/a
May 23, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $35.15
Upside: n/a
Dec 17, 2018
Upgraded: Buy
Price Target: $65
Current: $186.75
Upside: n/a
Jun 15, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $1.57
Upside: n/a
Feb 16, 2018
Downgraded: Hold
Price Target: n/a
Current: $379.57
Upside: n/a
Jan 4, 2018
Upgraded: Buy
Price Target: $52
Current: $10.94
Upside: n/a
Dec 7, 2017
Initiated Coverage: Buy
Price Target: $47
Current: $40.23
Upside: n/a